Envisage report cover

Intracranial shunt device Market: COVID-19 Impact and Global Analysis Forecast to 2028

Published Date: May 2021

No. of Pages: 207

Status: Upcoming

Report Code: EMR100034

A shunt is a mechanical device developed for the transportation of the extra cerebrospinal fluid(CSF) from the point of re-absorption or the obstructionarea and it is embedded under the skin.Various types of shunts are available in the market. The shunt has mainly three components. The first and foremost portion is known as proximal portion of the shunt or the shunt catheter. The catheter is a small narrow tube, implanted into the ventricle of the brain. The catheter is implanted above the obstruction happened area. The next portion of the shunt is a connector, which eventually connectsthe valve and reservoir. The valve monitors the amount of fluid being taken from the blood, then the reservoir stores the blood until it is required for the drainage into the distal (bottom) end. The distal end or the last portion is a narrow small part of the tubing (catheter) which centrals to area of CSF where extra blood will lastly be utilized by the body. Intracranial shunt is also based on the same principal of working.
Intracranial shunt device market is estimated to boost up in the recent years as the number of people undergoing surgery is increasing day by day. The demand is anticipated to increase majorly in the developing regions such as Asia-Pacific and Latin America. This increasing demand is anticipated to be driven by increasing per-capita disposable incomes and rapid urbanization especially in developing economies of India, China, Indonesia, Brazil, Argentina and Korea among others. Europe and North

America is the highest consumer of intracranial shunt devices due to more advanced and latest technology being used and designed and better medical facilities are provided by the government to the citizens. Asia-Pacific is expected to flourish the intracranial shunt device market because of the rapidly increasing population and higher number of people getting treatment for the high cerebrospinal fluid related diseases. However, high cost of the surgery and the intracranial shunt device are the biggest reasons for the hampering of the market if the developing countries like India, Philippines, and other South East Asian countries.

Intracranial Shunt Device Market is segmented on the basis of product and on the basis of region. On the basis of product the intracranial shunt device market is segmented into CSF Shunts and CSF Drainage Systems. On the basis of region the intracranial shunt device market is segmented intoNorth America, Latin America, Europe, Middle East & Africa and Asia Pacific.
Key players in the global market are focusing on some of the major market strategies such as partnerships, mergers, collaborations and acquisitions in order to gain strength and good will in the ever competitive market. Moreover, they are investing more on E & D activities to strengthen their goodwill in the ever competitive market. Also, they are focusing on acquiring local players especially in developing countries such as Russia, India, China, Netherlands, Indonesia, Denmark, Poland, New Zealand, Mexico, Argentina and Colombia among others. Some of the major players in the global market include Karl Storz, Machida Endoscope, Johnson & Johnson, Medicon, Medtronic, GammaStar Group, Mevion Medical Systems, Accuray, Elekta, and Optivus Proton Tharapy.

Intracranial Shunt Device Market is segmented
On the basis of product
• CSF Shunts
• CSF Drainage Systems
On the basis of region
• North America
• Latin America
• Europe
• Middle East & Africa
• Asia Pacific
Market By Geography
Market By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Australia
o Rest of Asia-Pacific
• Latin America
o Brazil
o Chile
o Rest of Latin America
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA

The Leading Key Players in Intracranial Shunt Device Market

Karl Storz
Machida Endoscope
Johnson & Johnson
GammaStar Group
Mevion Medical Systems
Optivus Proton Tharapy.